EGFR and lung adenocarcinoma: To investigate the role of mitochondria in resistance to gefitinib, we capitalized on PC9M2, a gefitinib-resistant lung adenocarcinoma cell line that was generated by long-term exposure of a sensitive PC9 cell line carrying a 5 amino acid deletion in the EGFR tyrosine kinase domain targeted by gefitinib [5].